Climb Bio Inc
NASDAQ:CLYM
Climb Bio Inc
NASDAQ:CLYM
Price:
7.03
USD
-3.17%
Market Cap:
$479.3m
Balance Sheet
Balance Sheet Decomposition
Climb Bio Inc
Climb Bio Inc
Balance Sheet Decomposition is not available for
Climb Bio Inc
Climb Bio Inc
Balance Sheet
Climb Bio Inc
Climb Bio Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
21
|
21
|
47
|
44
|
93
|
87
|
36
|
|
| Cash Equivalents |
21
|
21
|
47
|
44
|
93
|
87
|
36
|
|
| Short-Term Investments |
0
|
0
|
90
|
80
|
14
|
64
|
65
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
0
|
2
|
12
|
11
|
3
|
3
|
5
|
|
| Total Current Assets |
21
|
22
|
148
|
134
|
110
|
155
|
106
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Other Long-Term Assets |
0
|
3
|
25
|
0
|
0
|
62
|
61
|
|
| Total Assets |
21
N/A
|
25
+15%
|
173
+604%
|
135
-22%
|
110
-18%
|
217
+97%
|
168
-23%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
0
|
1
|
2
|
|
| Accrued Liabilities |
0
|
1
|
5
|
5
|
3
|
4
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
3
|
6
|
6
|
3
|
5
|
7
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
3
+288%
|
6
+94%
|
6
+5%
|
3
-54%
|
5
+85%
|
7
+37%
|
|
| Equity | ||||||||
| Common Stock |
26
|
47
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
8
|
28
|
76
|
121
|
156
|
230
|
290
|
|
| Additional Paid In Capital |
2
|
3
|
243
|
250
|
264
|
442
|
450
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
21
N/A
|
22
+5%
|
167
+674%
|
129
-23%
|
108
-16%
|
212
+97%
|
160
-24%
|
|
| Total Liabilities & Equity |
21
N/A
|
25
+15%
|
173
+604%
|
135
-22%
|
110
-18%
|
217
+97%
|
168
-23%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
25
|
25
|
26
|
27
|
28
|
67
|
48
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
